Celldex Therapeutics | CLDX - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
AbbVie USD 1.77B 1.75B 2025-06
Agenus USD 35.32M 2.51M 2025-12
Amgen USD 540M 1000K 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Celldex Therapeutics USD 66.57M 20K 2026-03
Glaxosmithkline GBP 4.08B 49.43M 2025-12
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Northwest Biotherapeutics USD 1.52B 1.52B 2025-09
Pfizer USD 5.7B 13M 2026-03
Rigel Pharmaceuticals USD 17K 158K 2024-06
Roche Holding CHF 795.62M 699.54K 2025-12